ADSUNIB™ 50
Brand Name: ADSUNIB™ 50
Composition: Sunitinib Malate Capsules
Quantity: 28 Capsules
Manufacturer/Marketer: ADLEY
Product Description
Medical Info
ADSUNIB™ 50 is a prescription oncology medication containing Sunitinib Malate (50 mg). Classified as a multi-targeted tyrosine kinase inhibitor (TKI), it works by blocking specific proteins on cancer cells that signal them to grow and divide, while also inhibiting angiogenesis—the growth of new blood vessels that supply tumors. This advanced therapy is primarily indicated for the treatment of renal cell carcinoma (advanced kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). Due to its complex mechanism and potential toxicities, therapy must be strictly managed by a qualified oncologist.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
